Evidence map›Paper›PMID 30356099›Full record

ReviewGenetics in medicine : official journal of the American College of Medical Genetics2019

The phenotypic spectrum of WWOX-related disorders: 20 additional cases of WOREE syndrome and review of the literature.

Juliette Piard, Lara Hawkes, Mathieu Milh, Laurent Villard, Renato Borgatti, Romina Romaniello, Melanie Fradin, Yline Capri, Delphine Héron, Marie-Christine Nougues and 21 more

Erratum issuedOpen access · hybridAbstract readCase ReportsReview
In one paragraph

Review in Genetics in medicine : official journal of the American College of Medical Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Zfra Overrides WWOX in Suppressing the Progression of Neurodegeneration.International journal of molecular sciences · 2024
    Review
  13. Case report: Adult patient withFrontiers in genetics · 2024
    Article
  14. Frontiers in pediatrics · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 20 institutions in 6 countries.

Juliette PiardCentre de Génétique Humaine, Université de Franche-Comté, CHU Besançon, Besançon, France.
Lara HawkesOxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Mathieu MilhAix Marseille Univ, Inserm, MMG, Marseille, France.
Laurent VillardAix Marseille Univ, Inserm, MMG, Marseille, France.
Renato BorgattiNeuropsychiatry and Neurorehabilitation Unit, Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Italy.
Romina RomanielloNeuropsychiatry and Neurorehabilitation Unit, Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Italy.
Melanie FradinService de Génétique, CLAD Ouest, CHU Rennes, Rennes, France.
Yline CapriDépartement de Génétique, Hôpital Robert Debré, APHP Paris, Paris, France.
Delphine HéronAPHP, Département de Génétique, Centre de Référence Déficiences Intellectuelles de Causes Rares, Groupe Hospitalier Pitié Salpêtrière et GHUEP Hôpital Trousseau, Sorbonne Université, GRC "Déficience Intellectuelle et Autisme", Paris, France.
Marie-Christine NouguesNeuropédiatrie et Unité d'électrophysiologie clinique, Centre de Référence des Maladies Neuromusculaires de l'EST parisien et DHU I2B, Hôpital d'Enfants Armand Trousseau, Paris, France.
Caroline NavaDépartement de Génétique, Sorbonne Universités, Institut du Cerveau et de la Moelle épinière, ICM, Inserm U1127, CNRS UMR 7225, APHP, Hôpital de la Pitié Salpêtrière, Paris, France.
Oana Tarta ArsenePediatric Neurology Clinic, "Alexandru Obregia" Clinical Psychiatry Hospital, "Carol Davila" University of Medicine, Bucharest, Romania.
Debbie ShearsOxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
John TaylorOxford Medical Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.
Alistair PagnamentaNIHR Oxford Biomedical Research Centre, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Jenny C TaylorNIHR Oxford Biomedical Research Centre, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Yoshimi SogawaDivision of Pediatric Neurology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA.
Diana JohnsonDepartment of Clinical Genetics, Sheffield Children's NHS Trust, Sheffield, United Kingdom.
Helen FirthDepartment of Clinical Genetics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Pradeep VasudevanClinical Genetics Department, University Hospitals Leicester NHS Trust, Leicester, UK.
Gabriela JonesClinical Genetics Department, University Hospitals Leicester NHS Trust, Leicester, UK.
Marie-Ange Nguyen-MorelService de Neurologie pédiatrique, Hopital Couple Enfant, CHU Grenoble Alpes, Grenoble, France.
Tiffany BusaMedical Genetics, La Timone Children's Hospital, AP-HM, Marseille, France.
Agathe RoubertieDépartement de Neuropédiatrie, Centre Hospitalier Universitaire de Montpellier, INSERM U 1051, Institut des Neurosciences de Montpellier, Montpellier, France.
Myrthe van den BornDepartment for Clinical Genetics, Erasmus MC, Rotterdam, Netherlands.
Elise Brischoux-BoucherCentre de Génétique Humaine, Université de Franche-Comté, CHU Besançon, Besançon, France.
Michel KoenigEA7402 Institut Universitaire de Recherche Clinique, and Laboratoire de Génétique Moléculaire, CHU and Université de Montpellier, Montpellier, France.
Cyril MignotAPHP, Département de Génétique, Centre de Référence Déficiences Intellectuelles de Causes Rares, Groupe Hospitalier Pitié Salpêtrière et GHUEP Hôpital Trousseau, Sorbonne Université, GRC "Déficience Intellectuelle et Autisme", Paris, France.
DDD Study
Usha KiniOxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. usha.kini@ouh.nhs.uk.
Christophe PhilippeLaboratoire de génétique, Innovations en diagnostic génomique des maladies rares, Plateau Technique de Biologie, CHU Dijon, Dijon, France.
Inserm · FRCentre for Human Genetics · GBIRCCS Eugenio Medea · ITOxford University Hospitals NHS Trust · GBSorbonne Université · FRUniversité de franche-comté · FRUniversity Hospitals of Leicester NHS Trust · GBAssistance Publique – Hôpitaux de Paris · FRCambridge University Hospitals NHS Foundation Trust · GBCarol Davila University of Medicine and Pharmacy · ROCentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Universitaire de Rennes · FRCentre National de la Recherche Scientifique · FRChildren's Hospital of Pittsburgh · USErasmus MC · NLHôpital Armand-Trousseau · FRHôpital de la Timone · FROxford Health NHS Foundation Trust · GBSheffield Children's NHS Foundation Trust · GBUniversité de Montpellier · FR

Funding

Department of HealthWellcome TrustWellcome Trust 090532/Z/09/ZWellcome Trust WT098051
6 · The paper itself

Abstract

purposeGermline WWOX pathogenic variants have been associated with disorder of sex differentiation (DSD), spinocerebellar ataxia (SCA), and WWOX-related epileptic encephalopathy (WOREE syndrome). We review clinical and molecular data on WWOX-related disorders, further describing WOREE syndrome and phenotype/genotype correlations.

methodsWe report clinical and molecular findings in 20 additional patients from 18 unrelated families with WOREE syndrome and biallelic pathogenic variants in the WWOX gene. Different molecular screening approaches were used (quantitative polymerase chain reaction/multiplex ligation-dependent probe amplification [qPCR/MLPA], array comparative genomic hybridization [array-CGH], Sanger sequencing, epilepsy gene panel, exome sequencing), genome sequencing.

resultsTwo copy-number variations (CNVs) or two single-nucleotide variations (SNVs) were found respectively in four and nine families, with compound heterozygosity for one SNV and one CNV in five families. Eight novel missense pathogenic variants have been described. By aggregating our patients with all cases reported in the literature, 37 patients from 27 families with WOREE syndrome are known. This review suggests WOREE syndrome is a very severe epileptic encephalopathy characterized by absence of language development and acquisition of walking, early-onset drug-resistant seizures, ophthalmological involvement, and a high likelihood of premature death. The most severe clinical presentation seems to be associated with null genotypes.

conclusionGermline pathogenic variants in WWOX are clearly associated with a severe early-onset epileptic encephalopathy. We report here the largest cohort of individuals with WOREE syndrome.

Indexed as

AdolescentChildChild, PreschoolDNA Copy Number VariationsEpilepsyEpileptic SyndromesFemaleGenetic Association StudiesHumansInfantMaleMutationMutation, MissenseSyndromeTumor Suppressor ProteinsWW Domain-Containing OxidoreductaseTumor Suppressor ProteinsWW Domain-Containing OxidoreductaseWWOX protein, humanencephalopathyepilepsyWWOX

Identifiers

PMID30356099
PMCPMC6752669
OpenAlexW2897951511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.